Countries South Korea

Lunit's AI Chest Screening to Deploy in Five Saudi Hospitals

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced an expansion of its services in the&nb...

 November 17, 2023 | News

South Korean Firm Lunit Raises $150 Million in Capital Boost

 Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics,  announced the successful completion ...

 November 16, 2023 | News

Lunit INSIGHT DBT receives FDA 510(k) clearance, poised to enter the world's largest DBT market

 Lunit  a leading provider of AI-powered solutions for cancer diagnostics and therapeutics,  announced that it has received U.S. Food and Dr...

 November 15, 2023 | News

Guardant Health Introduces Shield Blood Test for Colorectal Cancer in South Korea

Colorectal cancer (CRC) is one of the most commonly diagnosed cancers and the third-leading cause of cancer-related deaths in South Korea.1,2 Gua...

 November 13, 2023 | News

PharmAbcine Advances PMC-403 Clinical Trial in South Korea for Macular Degeneration

Safety Review Committee evaluated dose level 1 safety data of PMC-403 and approved advancing to the higher dose treatment.  The starting dose (0.7m...

 November 10, 2023 | News

GC Biopharma Seeks South Korean MFDS Approval for World's First Recombinant Anthrax Vaccine.

'GC1109' contains protective antigen (PA) as its active pharmaceutical ingredients produced by recombinant DNA technology which delivers 2 types of protein...

 November 06, 2023 | News

Curocell Completes Korea's First Phase 2 Clinical Trial for Next-Generation CAR-T

  Anbal-cel argeting DLBCL completes phase 2 trial Anticipation growing over Korea's first CAR-T therapy ahead of regulatory review Commerci...

 November 02, 2023 | News

Lunit Enters into Research Collaboration to Explore the Use of AI to Improve the Effectiveness of Immunotherapy

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced a research collaboration with The ...

 October 30, 2023 | News

Samsung Biologics and Kurma Partners Forge Biologics Development & Manufacturing Alliance for Kurma's Portfolio

- Samsung Biologics to provide de-risking, development, manufacturing services, and seamless transitions for biologics from early stages of developmen...

 October 25, 2023 | News

VUNO Secures FDA 510(k) Clearance for VUNO Med®-DeepBrain®

VUNO Med®-DeepBrain® is intended to automate the current manual process of identifying, labeling, and quantifying segmentable brain structures from...

 October 24, 2023 | News

Seegene Strengthens ESG Commitment with 100% Recyclable, Styrofoam-Free Shipping Boxes in South Korea

100% recyclable package made with eco-friendly and FSC-certified materials to proactively meet evolving global environmental regulations Patent des...

 October 19, 2023 | News

ABL Bio Achieves Regulatory Clearance for Innovative Bispecific Antibody in Solid Tumor; GenScript ProBio Commends Milestone Collaboration

ABL103 is a novel T-cell engaging bispecific antibody and demonstrates efficacious anti-tumor activity via B7-H4 mediated 4-1BB activation in tumor mi...

 October 13, 2023 | News

Specialised Therapeutics Secures Exclusive License for Novel Ovarian Cancer Treatment from CanariaBio

 First ovarian cancer therapy for ST oncology portfolio .. Phase 2 study demonstrated oregovomab in combination with chemotherapy improved progress...

 October 13, 2023 | News

HanAll, Daewoong, and NurrOn Launch Phase 1 Study for HL192

HanAll Biopharma and Daewoong Pharmaceutical marked a pivotal step forward in the development of HL192 (ATH-399A) for the potential treatment of Parkinso...

 October 13, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close